Déanfar na Teicneolaíochtaí Sláinte Braite Trí Leithris seo a Thástáil go Cliniciúil sna SA, Iosrael agus an tSeapáin

Déanfar na Teicneolaíochtaí Sláinte Braite Trí Leithris seo a Thástáil go Cliniciúil sna SA, Iosrael agus an tSeapáin

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Meitheamh. The technology gains life-saving medical insights by analysing human excrement. Tá sraith de thrí phaitinn comhdaithe ag an gcuideachta a chlúdaíonn gnéithe dá braiteoir leithris leighis.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, An Eoraip, an tSeapáin agus an tSín.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Is féidir le teicneolaíocht OutSense foinse na fola feadh an chonair gastrointestinal a aithint.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

De réir POF OutSense Yfat Scialom, who predicts that “le pléascadh na míochaine digiteach, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, galair putóige athlastacha agus ionfhabhtuithe conradh urinary.

Its solution consists of a multispectral optical sensor, a light source and an autonomous screening device that includes a WiFi connection. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Information obtained from sampled blood, combined with additional analysis of the time from bleeding to excretion, provides details of the bleeding pathology. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense announced that CommuniCare, a large healthcare company with more than 90 healthcare facilities in the US, Cuirfear tús lena teicneolaíocht píolótach i mbliana. Chomh maith leis an píolótach seo, OutSense also plans to conduct clinical trials in Israel and Japan.

Tabhair cuairt ar Tuilleadh Nuacht ag Nuacht Viga.cc